MCL Clinical Trials

1230 trials from ClinicalTrials.gov. Recruiting trials shown first.

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

NCT01769911·NA·Fred Hutchinson Cancer Center

carmustinecytarabinemelphalanetoposideO6-benzylguanine+3 more

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT02242097·PHASE2·Northwestern University·37 enrolled

ibrutiniblaboratory biomarker analysis

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

NCT02328014·PHASE1 / PHASE2·Acerta Pharma BV·40 enrolled

AcalabrutinibACP-319

CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT02168907·PHASE1·Wake Forest University Health Sciences·1 enrolled

6,8-bis(benzylthio)octanoic acidbendamustine hydrochloriderituximablaboratory biomarker analysis

A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

NCT02268851·PHASE1·Dana-Farber Cancer Institute·45 enrolled

TGR-1202Ibrutinib

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

NCT02274506·PHASE1·M.D. Anderson Cancer Center

CyclophosphamideFludarabineT-Cell Infusion

Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

NCT02145039·NA·Masonic Cancer Center, University of Minnesota·2 enrolled

FludarabineCyclophosphamideTotal Body IrradiationHaploidentical stem cell transplant

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

NCT02240719·PHASE1·University of California, Davis·20 enrolled

everolimusbendamustine hydrochloride

Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

NCT02267590·Royal Marsden NHS Foundation Trust·120 enrolled

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

NCT02238522·PHASE1·Zenith Epigenetics

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

NCT02142530·PHASE1·Massachusetts General Hospital·19 enrolled

CarfilzomibBelinostat

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

NCT02109224·PHASE1·National Cancer Institute (NCI)·72 enrolled

IbrutinibLaboratory Biomarker AnalysisPharmacological Study

Safety Study of SGN-CD70A in Cancer Patients

NCT02216890·PHASE1·Seagen Inc.·38 enrolled

Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma

NCT02169180·PHASE2·Janssen Pharmaceutical K.K.·16 enrolled

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913·PHASE1 / PHASE2·University of Chicago·55 enrolled

lenalidomideetoposideprednisonevincristine sulfatedoxorubicin hydrochloride+4 more

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

NCT02049541·PHASE1·Kami Maddocks, MD·18 enrolled

PI3K inhibitor BKM120rituximabPharmacodynamicsCorrelative studies

A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

NCT02042950·PHASE2·M.D. Anderson Cancer Center·6 enrolled

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

NCT01827579·PHASE1 / PHASE2·University College, London·37 enrolled

CD25/71 allodepleted donor T-cells

Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)

NCT01926665·PHASE1·M.D. Anderson Cancer Center·2 enrolled

CarfilzomibDexamethasone

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

NCT02134262·PHASE1 / PHASE2·Jichi Medical University·18 enrolled

Cyclophosphamide or BendamustineDose Level -1Dose Level 1Dose Level 2Dose Level 3

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

NCT02091063·PHASE1 / PHASE2·Jennifer Amengual·23 enrolled

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

NCT01996865·PHASE3·Celgene·503 enrolled

LenalidomideRituximab

A Phase II Study of Doxycycline in Relapsed NHL

NCT02086591·PHASE2·University of Rochester·7 enrolled

CART-19 Immunotherapy in Mantle Cell Lymphoma

NCT02081937·PHASE1 / PHASE2·Chinese PLA General Hospital·2 enrolled

anti-CD19-CAR vector-transduced T cells

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477·EARLY_PHASE1·Case Comprehensive Cancer Center·33 enrolled

busulfanetoposidecyclophosphamideperipheral blood stem cell transplantationautologous hematopoietic stem cell transplantation

Ublituximab + Ibrutinib in Select B-cell Malignancies

NCT02013128·PHASE1 / PHASE2·TG Therapeutics, Inc.·66 enrolled

UblituximabIbrutinib

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

NCT01652014·PHASE2·University of Medicine and Dentistry of New Jersey

cyclophosphamidefludarabine phosphatemycophenolate mofetilallogeneic hematopoietic stem cell transplantationumbilical cord blood transplantation+5 more

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

NCT01163201·PHASE1 / PHASE2·Masonic Cancer Center, University of Minnesota

Treg cellsCD3+ Teff cellsFludarabineCyclophosphamideTotal body irradiation+1 more

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

NCT00889408·PHASE1·Masonic Cancer Center, University of Minnesota·25 enrolled

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies

NCT01998035·PHASE1 / PHASE2·Columbia University·58 enrolled

RomiDEPsin 10 MG/M2Oral 5-Azacitidine 100 MGRomidepsin 14 MG/M2Oral 5-Azacitidine 200 MGOral 5-Azacitidine 300 MG

← PreviousPage 16 of 41Next →